knowledge -WSS

knowledge

author：hotspot 2025-09-27 12:55:30 - browse：7

Eli Lilly headquarters in Indianapolis – pharmaceutical coverage from STAT — Darron Cummings/AP

LONDON — A U.K. government agency on Tuesday said that it won’t recommend Eli Lilly’s Mounjaro — part of a new class of medications that help patients lose weight — for people with type 2 diabetes without additional evidence.

Mounjaro, also known as tirzepatide, has U.S. approval for type 2 diabetes and is expected to win the regulatory green light for obesity later this year. It is one of several medications, along with Wegovy and Ozempic from Novo Nordisk, that have shown dramatic weight loss results, creating a surge in demand and blockbuster sales expectations.

But in draft guidance, the U.K.’s National Institute for Health and Care Excellence, which assesses the cost-effectiveness of medications, said it had asked Lilly for more data “to address the uncertainties in the clinical evidence, when compared to all relevant alternative treatments.” NICE recommendations are used by the National Health Service to determine whether to provide certain medications.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Cancer drug shortages should be causing more outrage
Next article： Thousands protest in Iraq for a second day over burning of Quran in Sweden

hotspot

WSS

Feds fine Medicare Advantage plans for overcharging members

Biden slams SCOTUS affirmative action decision: 'Discrimination still exists in America'

Prince Harry seeks over $550,000 in phone hacking lawsuit against British tabloid publisher

Prince Harry seeks over $550,000 in phone hacking lawsuit against British tabloid publisher

Why do we get seasonal allergies?

What Wagner Group's armed rebellion could mean for Russia's endgame in Ukraine

hotspot

knowledge

leisure time

Guidelines to prevent youth baseball injuries need more muscle

Anger, defiance, fear over Supreme Court decision to block student loan forgiveness

Alkermes shareholders re

Here's how to stay safe from wildfire smoke amid reduced air quality

Walensky prepares to leave CDC — and Congress — behind

Medical experts exlpore how to eliminate bias in clinical algorithms

Anesthesiologist group: stop taking Ozempic before surgery

Why do we get seasonal allergies?

After affirmative action ruling, medical educators look to 'holistic review'

AstraZeneca challenges Medicare drug negotiation program

entertainment

ADA: All diabetes patients should be screened for liver condition

Psilocybin's anti

Unicorn down: Following layoffs, Biofourmis CEO quietly departs

CDC advisory panel says seniors 'may' get RSV vaccine

Synthetic human embryos? Researchers say term is overblown

What do new weight loss drugs mean for bariatric surgery?

knowledge

hotspot

hotspot

knowledge